Keele Research Repository

Article

Paliouras, AR, Buzzetti, M, Shi, L, Donaldson, IJ, Magee, P, Sahoo, S, Leong, H, Fassan, M, Carter, M, Di Leva, G ORCID: https://orcid.org/0000-0001-6759-8682, Krebs, MG, Blackhall, F, Lovly, CM and Garofalo, M (2020) Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition. EMBO Molecular Medicine, 12 (7).

Kessler, DS, MacNeil, SJ, Tallon, D, Lewis, G, Peters, TJ, Hollingworth, W, Round, J, Burns, A, Chew-Graham, CA, Anderson, IM, SHEPHERD, T, Campbell, J, Dickens, CM, Carter, M, Jenkinson, C, Macleod, U, Gibson, H, Davies, S and Wiles, NJ (2018) MIRtazapine added to SSRIs or SNRIs for Treatment Resistant Depression in Primary Care: a placebo controlled randomised trial (MIR). BMJ, 363.

Kessler, DS, MacNeill, SJ, Tallon, D, Lewis, G, Peters, TJ, Hollingworth, W, Round, J, Burns, A, Chew-Graham, CA, Anderson, IM, Shepherd, T, Campbell, J, Dickens, CM, Carter, M, Jenkinson, C, Macleod, U, Gibson, H, Davies, S and Wiles, NJ (2018) Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR). BMJ, 363. k4218 - ?.